CDNA
CareDx Inc
NASDAQ: CDNA · HEALTHCARE · DIAGNOSTICS & RESEARCH
$47.31
+0.17% today
Updated 2026-08-12
Market cap
$2.35B
P/E ratio
22.64
P/S ratio
5.14x
EPS (TTM)
$2.01
Dividend yield
—
52W range
$11 – $50
Volume
1.1M
CareDx Inc (CDNA) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$47.31
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$62.15
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.3B | $0.3B | $0.3B | $0.3B | $0.4B | $0.4B | $0.5B | $0.6B | $0.7B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 14.59% (capped 20%) · P/E: 22.64x (capped 25x) · Margin: 24.20%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.